InvestorsObserver is giving Moderna Inc (MRNA) an Analyst Rating Rank of 23, meaning MRNA is ranked higher by analysts than 23% of stocks. The average price target for MRNA is $136.753 and analyst’s rate the stock as a Buy.
Wall Street analysts are rating MRNA a Buy today. Find out what this means to you and get the rest of the rankings on MRNA!
Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company's balance sheet. This information allows investors to make decisions ahead of the curve.
InvestorsObserver combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.
What's Happening With Moderna Inc Stock Today?
Moderna Inc (MRNA) stock is lower by -1.39% while the S&P 500 has gained 0.04% as of 10:56 AM on Thursday, Mar 28. MRNA is down -$1.54 from the previous closing price of $110.59 on volume of 871,578 shares. Over the past year the S&P 500 has risen 30.36% while MRNA is down -26.71%. MRNA lost -$12.34 per share the over the last 12 months.
Click Here to get the full Stock Report for Moderna Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
